Galderma Group AG

Galderma Group AG is a specialist in dermatology, operating as a pure-play leader dedicated exclusively to the research, development, and commercialization of products for skin health. With a heritage spanning over four decades, the company delivers a science-driven portfolio across the full spectrum of dermatology, including injectable aesthetics, dermatological skincare, and therapeutic solutions for a variety of skin conditions. Galderma’s flagship brands, such as Dysport/Azzalure, Restylane, Cetaphil, and Differin, are well-recognized among healthcare professionals and consumers alike for their efficacy and quality. The company serves a global market, producing hundreds of millions of units annually and supporting both medical and aesthetic skin treatments. Through close collaboration with healthcare providers and a consistent focus on innovation, Galderma Group AG plays a pivotal role in advancing dermatological science and addressing a wide range of consumer and patient needs related to skin health.